Utility and limitations of Addenbrooke's cognitive examination-revised for detecting mild cognitive impairment in Parkinson's disease

Dementia and Geriatric Cognitive Disorders

Volumn 31, Issue 5, 2011, Pages 349-357

  Komadina, Natalie C ^a   Terpening, Zoe ^b   Huang, Yue ^a   Halliday, Glenda M ^a   Naismith, Sharon L ^b   Lewis, Simon J G ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Addenbrooke's cognitive examination; Dementia; Mild cognitive impairment; Parkinson's disease; Screening

Indexed keywords

CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE INHIBITOR;

ADDENBROOKE COGNITIVE EXAMINATION REVISED; AGED; ARTICLE; EDUCATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

AGED; COGNITION DISORDERS; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; REPRODUCIBILITY OF RESULTS; ROC CURVE; SOCIOECONOMIC FACTORS; VERBAL BEHAVIOR;

EID: 80955175369     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000328165     Document Type: Article

References (56)

1. Chaudhuri KR, Healy DG, Schapira AH: Non-motor symptoms of Parkinsons disease: diagnosis and management. Lancet Neurol 2006; 5: 235-245. (Pubitemid 43238347) (Pubitemid 43238347)
2. Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, Evidente VG, Shill HA, Adler CH: Defining mild cognitive impairment in Parkinsons disease. Mov Disord 2007; 22: 1272-1277. (Pubitemid 47325034) (Pubitemid 47325034)
3. Hely MA, Reid WGJ, Adena MA, Halliday GM, Morris JGL: The Sydney Multicenter Study of Parkinsons Disease: the inevitability of dementia at 20 years. Mov Disord 2008; 23: 837-844.
4. Foltynie T, Brayne CEG, Robbins TW, Barker RA: The cognitive ability of an incident cohort of Parkinsons patients in the UK. The CamPaIGN study. Brain 2004; 127:550-560. (Pubitemid 38295472) (Pubitemid 38295472)
5. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Ritchie K, Rossor M, Thal L, Winblad B: Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985-1992. (Pubitemid 33143977) (Pubitemid 33143977)
6. Williams-Gray CH, Foltynie T, Brayne CEG, Robbins TW, Barker RA: Evolution of cognitive dysfunction in an incident Parkinsons disease cohort. Brain 2007; 130: 1787-1798. (Pubitemid 47343805) (Pubitemid 47343805)
7. Janvin CC, Aarsland D, Larsen JP: Cognitive predictors of dementia in Parkinsons disease: a community-based, 4-year longitudinal study. J Geriatr Psychiatry Neurol 2005; 18: 149-154. (Pubitemid 41284965) (Pubitemid 41284965)
8. Knopman DS, Boeve BF, Petersen RC: Essentials of the proper diagnoses of mild cognitive impairment, dementia, and major subtypes of dementia. Mayo Clin Proc 2003; 78: 1290-1308. (Pubitemid 37193520) (Pubitemid 37193520)
9. Petersen RC: Mild cognitive impairment as a diagnostic entity. J Intern Med 2004; 256: 183-194. (Pubitemid 39222988) (Pubitemid 39222988)
10. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinsons disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
11. Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M: Diagnostic procedures for Parkinsons disease dementia: recommendations from the Movement Disorder Society Task Force. Mov Disord 2007; 22: 2314-2324. (Pubitemid 351155975) (Pubitemid 351155975)
12. Verbaan D, Marinus J, Visser M, van Rooden SM, Stiggelbout AM, Middelkoop HA, van Hilten JJ: Cognitive impairment in Parkinsons disease. J Neurol Neurosurg Psychiatry 2007; 78: 1182-1187.
13. Riedel O, Klotsche J, Spottke A, Deuschl G, Förstl H, Henn F, Heuser I, Oertel W, Reichmann H, Riederer P, Trenkwalder C,Dodel R, Wittchen HU: Cognitive impairment in 873 patients with idiopathic Parkinsons disease: results from the German Study on Epidemiology of Parkinsons Disease with Dementia (GEPAD). J Neurol 2008; 255: 255-264.
14. Sollinger AB, Goldstein FC, Lah JJ, Levey AI, Factor SA: Mild cognitive impairment in Parkinsons disease: subtypes and motor characteristics. Parkinsonism Relat Disord 2010; 16: 177-180.
15. Janvin CC, Aarsland D, Larsen JP, Hugdahl K: Neuropsychological profile of patients with Parkinsons disease without dementia. Dement Geriatr Cogn Disord 2003; 15: 126-131. (Pubitemid 36206641) (Pubitemid 36206641)
16. Muslimović D, Post B, Speelman JD, Schmand B: Cognitive profile of patients with newly diagnosed Parkinsons disease. Neurology 2005; 65: 1239-1245. (Pubitemid 41508217) (Pubitemid 41508217)
17. Kim JW, Jo HY, Park MJ, Cheon S: Mild cognitive impairment in Parkinsons disease. J Mov Disord 2008; 1: 19-25.
18. Aarsland D, Bronnick K, Larsen JP, Tysenes OB, Alves G, Norwegian Park West Study Group: Cognitive impairment in incident, untreated Parkinson disease: The Norwegian Park West Study. Neurology 2009; 72: 1121-1126.
19. Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, Emre M: Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 2010; 75: 1062-1069.
20. Janvin CC, Larsen JP, Aarsland D, Hugdahl K: Subtypes of mild cognitive impairment in Parkinsons disease: progression to dementia. Mov Disord 2006; 21: 1343-1349. (Pubitemid 44613283) (Pubitemid 44613283)
21. Mamikonyan E, Moberg PJ, Siderowf A, Duda JE, Have TT, Hurtig HI, Stern MB, Weintraub D: Mild cognitive impairment is common in Parkinsons disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord 2009; 15: 226-231.
22. Kulisevsky J, Pagonabarraga J: Cognitive Impairment in Parkinsons disease: tools for diagnosis and assessment. Mov Disord 2009; 24: 1103-1110.
23. Lewis SJG, Dove A, Robbins TW, Barker RA, Owen AM: Cognitive impairments in early Parkinsons disease are accompanied by reductions in activity in frontostriatal neural circuitry. J Neurosci 2003; 23: 6351-6356. (Pubitemid 36875637) (Pubitemid 36875637)
24. Mowszowski L, Batchelor J, Naismith SL: Early intervention for cognitive decline: can cognitive training be used as a selective prevention technique? Int Psychogeriatr 2010; 22: 537-548.
25. Vale S: Current Management of the cognitive dysfunction in Parkinsons disease: how far have we come? Exp BiolMed 2008; 233: 941-951.
26. Zadikoff C, Fox SH, Tang-Wai DF, Thomsen T, de Bie RM, Wadia P, Miyasaki J, Duff- Canning S, Lang AE, Marras C: A comparison of the Mini Mental State Exam to the Montreal Cognitive Assessment in identifying cognitive deficits in Parkinsons disease. Mov Disord 2008; 23: 297-299. (Pubitemid 351311567) (Pubitemid 351311567)
27. Folstein MF, Folstein SE, McHugh PR: Mini- Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
28. Bak TH, Mioshi E: A cognitive bedside assessment beyond the MMSE: the Addenbrooke's Cognitive Examination. Pract Neurol 2007; 7: 245-249. (Pubitemid 47193708) (Pubitemid 47193708)
29. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H: The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J American Geriatr Soc 2005; 53: 695-699. (Pubitemid 41623495) (Pubitemid 41623495)
30. Gill DJ, Freshman A, Blender J, Ravina B: The Montreal Cognitive Assessment as a screening tool for cognitive impairment in Parkinsons disease. Mov Disord 2008; 23: 1043-1046.
31. Nazem S, Siderowf AD, Duda JE, Have TT, Colcher A, Horn SS, Moberg PJ, Wilkinson JR, Hurtig HI, Stern MB, Weintraub D: The Montreal Cognitive Assessment performance in patients with Parkinsons disease with 'normal' global cognition according to Mini-Mental State Examination Score. J American Geriatr Soc 2009; 57: 304-308.
32. Dalrymple-Alford JC, MacAskill MR, Nakas CT, Livingston L, Graham C, Crucian GP, Melzer TR, Kirwan J, Keenan R, Wells S,Porter RJ, Watts R, Anderson TJ: The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology 2010; 75: 1717-1725.
33. Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR: A brief cognitive test battery to differentiate Alzheimers disease and frontotemporal dementia. Neurology 2000; 55: 1613-1620.
34. Bier JC, Ventura M, Donckels V, Van Eyll E, Claes T, Slama H, Fery P, Vokaer M, Pandolfo M: Is the Addenbrooke's Cognitive Examination effective to detect frontotemporal dementia? J Neurol 2004; 251: 428-431. (Pubitemid 38501300) (Pubitemid 38501300)
35. Bak TH, Rogers TT, Crawford LM, Hearn VC, Mathuranath PS, Hodges JR: Cognitive bedside assessment in atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 2005; 76: 420-422. (Pubitemid 40299137) (Pubitemid 40299137)
36. Dudas RB, Berrios GE, Hodges JR: The Addenbrooke's Cognitive Examination (ACE) in the differential diagnosis of early dementias versus affective disorder. Am J Geriatr Psychiatry 2005; 13: 218-226. (Pubitemid 41031090) (Pubitemid 41031090)
37. Galton CJ, Erzincxlioglu S, Sahakian BJ, Antoun N, Hodges JR: A comparison of the Addenbrooke's Cognitive Examination (ACE), conventional neuropsychological assessment, and simple MRI-based medial temporal lobe evaluation in the early diagnosis of Alzheimers disease. Cogn Behav Neurol 2005; 18: 144-150. (Pubitemid 41407450) (Pubitemid 41407450)
38. Larner AJ: Addenbrooke's Cognitive Examination (ACE) for the diagnosis and differential diagnosis of Dementia. Clin Neurol Neurosurg 2007; 109: 491-494. (Pubitemid 46783199) (Pubitemid 46783199)
39. Reyes MA, Lloret SP, Gerscovich ER, Martin ME, Leiguarda R, Merello M: Addenbrooke's Cognitive Examination validation in Parkinsons disease. Eur J Neurol 2009; 16: 142-147.
40. Larner AJ: An audit of the Addenbrooke's Cognitive Examination (ACE) in clinical practice. Int J Geriatr Psychiatry 2005; 20: 593-594. (Pubitemid 40873354) (Pubitemid 40873354)
41. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR: The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 2006; 21: 1078-1085. (Pubitemid 44762726) (Pubitemid 44762726)
42. Alexopoulos P, Ebert A, Richter-Schmidinger T, Schöll E, Natale B, Aguilar CA, Gourzis P, Weih M, Perneczky R, Diehl-Schmid J, Kneib T, Förstl H, Kurz A, Danek A, Kornhuber J: Validation of the German Revised Addenbrooke's Cognitive Examination for detecting mild cognitive impairment, mild dementia in Alzheimers disease and frontotemporal lobar degeneration. Dement Geriatr Cogn Disord 2010; 29: 448-456.
43. Gibb WR, Lees AJ: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinsons disease. J Neurol Neurosurg Psychiatry 1988; 51: 745-752.
44. Fahn S, Elton RL, UPDRS Development Committee: Unified Parkinsons Disease Rating Scale; in Fahn S, Marsden CD, Calne DB, Goldstein M (eds): Recent Developments in Parkinsons Disease. Florham Park, Macmillan, 1987, pp 153-163.
45. Katzenschlager R, Head J, Schrag A, Ben- Shlomo Y, Evans A, Lees AJ: Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD. Neurology 2008; 71: 474-480.
46. Beck AT, Steer RA, Brown GK: BDI-II Manual. San Antonio, Psychological Corporation, 1996.
47. Naismith SL, Pereira M, Shine JM, Lewis SJG: How well do caregivers detect mild cognitive change in Parkinsons disease? Mov Disord 2011; 1: 161-164.
48. Wechsler D: Wechsler Memory Scale. San Antonio, Psychological Corporation, 1997.
49. Reitan RM, Wolfson D: The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. Tucson, Neuropsychology Press, 1993.
50. Benton AL: Problems of test construction in the field of aphasia. Cortex 1967; 3: 32-58.
51. Nelson HE, Willison, J: National Adult Reading Test (NART): Test Manual, ed 2. Windsor, NFER-Nelson, 1991.
52. Wechsler D: Manual for the Wechsler Adult Intelligence Scale, ed 3. San Antonio, Psychological Corporation, 1997.
53. Tombaugh TN, Kozak J, Rees L: Normative data for the Controlled Oral Word Association Test, personal communication 1996; in Spreen O, Strauss E (eds): A Compendium of Neuropsychological Tests. Administration, Norms and Commentary. New York, Oxford University Press, 1998, pp 447-464.
54. Spreen O, Strauss E: A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, ed 2. New York, Oxford University Press, 1998.
55. Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, Brayne C, Kolachana BS, Weinberger DR, Sawcer SJ, Barker RA: The distinct cognitive syndromes of Parkinsons disease: 5 year followup of the CamPaIGN cohort. Brain 2009; 132: 2958-2969.
56. Fernandez HH, Crucian GP, Okun MS, Price CC, Bowers D: Mild cognitive impairment in Parkinsons disease: the challenge and the promise. Neuropsychiatr Dis Treat 2005; 1: 37-50.